Showing 48 out of 63 results
Brexit “no deal” technical notices published on intellectual property and life sciences sector issues
The latest tranche of “no deal” technical notices was released yesterday afternoon by the UK Government. Amongst them are several notices that highlight …
Brexit White Paper highlights importance of Intellectual Property rights post-Brexit
Significantly, for those with interests in IP rights, the UK Government's White Paper on Brexit makes encouraging noises about future recognition and …
Patent and Pharma Update, July 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector English courts begin to consider the new …
Pfizer beats the ACCC again – implications for pharma
The Full Court of the Federal Court of Australia has dismissed an appeal by the ACCC against an earlier judgment in relation to pharmaceutical company …
Herbert Smith Freehills' New Milan Office Wins Another Haul of Awards
Herbert Smith Freehills Partner Laura Orlando and new recruit Senior Associate Sara Balice walked away with two prestigious accolades at the Italian …
ADVOCATE GENERAL PROVIDES OPINION ON THE INTERPRETATION OF ARTICLE 3(a) SPC REGULATION
Advocate General Wathelet (the "AG") has provided his opinion to the Court of Justice of the European Union (the "CJEU") on the interpretation of Article …
Herbert Smith Freehills Marks Milan office opening with launch party
Business leaders gathered together this week to celebrate Herbert Smith Freehills' official office opening at a party in Milan. More than 100 guests …
Arbitrating Pharma Disputes On The Rise – Planning Ahead Makes Sense
Pharmaceutical companies risk coming up against complex and high value disputes in their everyday dealings and operations, and we are increasingly seeing …
Brexit 'The view from Brussels' – developments in January
January was dominated by the strikingly public discussion of the content of the next supplement to the negotiating guidelines that the European Council …
Pre-trial discovery of manufacturing process information for Etanercept biosimilar allowed
In this week’s important decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCAFC 193, the Full Court of the Federal Court of …
Patent and Pharma update - November 2017
Key recent developments in the United Kingdom and Europe relating to the patents and pharmaceutical sector. One of the most significant developments in …
The High Court considers the doctrine of equivalents in the context of patent infringement and novelty
The High Court in Generics (U.K.) v Yeda Research has considered the correct approach to the interpretation of patent claims in light of the recent …
Showing 48 out of 63 results
View more